TABLE 3.
Pathogena | PFTa | Presence of PFT effect |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Innate immune responses |
Barrier dysfunction | Vasoconstriction and -dilation and altered blood pressure | Vascular and ischemic necrosis | Immune evasion |
Hijacking of host factors | Programmed cell death of nonimmune cells | |||||
Inflammation | PRRs involved | Inflammasome activation | Cytotoxicity toward immune cells (direct and via programmed cell death) | Intracellular survival of pathogen | |||||||
S. pneumoniae | PLY | × | × | × | × | × | × | × | |||
GAS | SLO | × | × | × | × | × | × | ||||
SLS | × | × | |||||||||
GBS | β-h/c | × | × | × | × | ||||||
S. aureus | PVL | × | × | × | |||||||
Alpha-toxin | × | × | × | × | × | × | |||||
γ-hemolysin | × | ||||||||||
LukED | × | ||||||||||
LukGH | × | ||||||||||
B. anthracis | ALO | × | × | × | |||||||
C. botulinum | BLY | × | |||||||||
C. perfringens | β-toxin | × | × | × | |||||||
ε-toxin | × | × | |||||||||
PFO | × | × | |||||||||
C. septicum | Alpha-toxin | × | |||||||||
C. tetani | Tetanolysin | × | |||||||||
L. monocytogenes | LLO | × | × | ||||||||
M. tuberculosis | ESAT-6 | × | × | ||||||||
E. coli | HlyA | × | × | × | × | ||||||
V. cholerae | VCC | × | × |
See Table 2 for details on these pathogens and PFTs.